[Drug therapy of pulmonary embolism].
Heparin is indicated in pulmonary embolism suspicion, in minor and a part of submassive embolism. The dose is 15,000-20,000 U (acute) and 40,000 U/day subsequently. Fibrinolytic therapy with streptokinase or urokinase is indicated in massive embolism. Submassive embolism is treated by fibrinolysis if no contraindications against fibrinolysis are to be registered.
D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy*
D006493:Heparin
Die medikamentöse Therapie der Lungenembolie.